Bridgewater, N.J.-based Clinical Genomics launched Colvera, a blood-based test for colorectal cancer recurrence monitoring. Here’s what you need to know. 1. Colvera is a qualitative test that ...

When a person with cancer finds out they carry an inherited genetic variant that puts them at higher risk of cancer, the results can help inform their treatment or steps to prevent additional cancer.

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced today the validation and launch of OncoPrism ®-NSCLC, an ...

ST. LOUIS--(BUSINESS WIRE)--Cofactor Genomics, Inc., a clinical-stage company bridging the precision medicine gap by decoding RNA, announced the publication of their PREDAPT clinical trial ...

Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...

Bridgewater, N.J.-based Clinical Genomics, a biotechnology company focused on colorectal cancer diagnosis, has appointed four new hires to its leadership team. 1. Laurie Huard, now the company’s COO, ...

India’s genomics moment reached a critical inflection point in 2025. This momentum is not the result of a dramatic technological leap, but of genomic testing moving decisively into routine clinical ...

FORT MYERS, Fla. and FREMONT, Calif., April 29, 2025 /PRNewswire/ -- NeoGenomics, Inc. (NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, and Ultima Genomics, ...

The UC Santa Cruz Colligan Clinical Diagnostic Laboratory (CCDL) has received its CLIA certificate of registration from the California Department of Public Health, which clears the way for it to begin ...

The Alzheimer's Association released its first comprehensive clinical practice guidelines for the diagnosis, treatment, and care of Alzheimer's disease (AD) at the end of July. This landmark document ...